Log In
Print this Print this

genetically modified autologous human fibroblasts (GM-HDF-COL7) (FCX-013)

  Manage Alerts
Collapse Summary General Information
Company Fibrocell Science Inc.
DescriptionGenetically modified autologous human fibroblasts that combines Fibrocell's autologous fibroblast technology with Intrexon's UltraVector synthetic biology platform
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today